Alzheimer's Disease
Showing of 14 results
UH Cleveland Medical Center Currently Recruiting People with Early Alzheimer’s Disease for a Clinical Trial Evaluating Benfotiamine, a Synthetic Version of Thiamine (Vitamin B1)
Phase 2 study funded by the National Institute on Aging, part of the NIH, is evaluating effects of benfotiamine on cognitive function.
Synergy for Change Award to Morgan Stanley GIFT and Harrington Discovery Institute
Award highlights collaboration between for profit and non-profit achieving great impact.
University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLA™ for Treatment of Alzheimer’s Disease
UH Brain Health & Memory Center Begins KISUNLA (Donanemab) Infusions for Patients.
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Call for proposals focused on proteostasis, senescence, and other novel approaches.
University Hospitals Now Offering FDA-Approved Medication for Treatment of Alzheimer’s Disease
UH Brain Health & Memory Center Begins LEQEMBI® (lecanemab) Infusions for Patients
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Protect the Alzheimer’s Brain
Dr. Christiane Wrann of Massachusetts General Hospital selected for research aimed at using the novel exercise hormone irisin to treat Alzheimer’s disease
University Hospitals Part of Study Aiming to Prevent Alzheimer's Disease
November is Alzheimer’s Disease Awareness Month.
New Alzheimer's Disease Study Seeks Northeast Ohio Volunteers with Down Syndrome
As many as eight in 10 people with Down syndrome develop Alzheimer’s disease; new study needs volunteers to help identify causes and treatments